Fisher & Paykel Healthcare Corporation Limited
Symbol: FPH.AX
ASX
23.66
AUDDzisiejsza cena rynkowa
61.8116
Wskaźnik P/E
3.7087
Wskaźnik PEG
13.82B
Kapitalizacja MRK
- 0.01%
Rentowność DIV
Fisher & Paykel Healthcare Corporation Limited (FPH-AX) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 113.3 | 268.5 | 347.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0.5 | 185.3 | 257.7 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 237.9 | 169.2 | 210.5 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 342.4 | 332.4 | 248.8 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 31.1 | 52.2 | 39.4 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 724.6 | 822.4 | 846 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1074.7 | 887.2 | 811.1 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 80.1 | 80.4 | 73.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 80.1 | 80.4 | 73.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 93.5 | 84.2 | 102.6 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 90.4 | 77.4 | 74.8 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1338.7 | 1129.2 | 1062 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 2063.4 | 1951.6 | 1908 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 40.2 | 49.8 | 52.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 19.9 | 15.7 | 24.5 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 6.2 | 29.5 | 137.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 74 | 58.4 | 57.7 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 42.5 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 204.9 | 186.4 | 178.9 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 151 | 114.3 | 116.4 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 42.5 | 22.5 | 26.7 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 422.2 | 395.8 | 509.5 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 287.3 | 246.7 | 231.1 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 1123.6 | 1094.1 | 946.4 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 233.2 | 219.8 | 223.1 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -3.1 | -4.7 | -2 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1641.1 | 1555.9 | 1398.5 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2063.4 | 1951.6 | 1908 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1641.1 | 1555.9 | 1398.5 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 93.5 | 269.5 | 360.4 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 136.5 | 96.6 | 108.9 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 23.2 | 13.3 | 19.4 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 234.3 | 349.1 | 482 | |||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 92.7 | 88.9 | 78.2 | |||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 4.5 | -6.3 | -54.3 | |||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -250.1 | -216.3 | -214.7 | |||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -64.8 | -38.4 | -58.4 | |||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -40.5 | 48.6 | -4.7 | |||||||||||||||||||||||
cash-flows.row.inventory | 0 | -6.5 | -81.8 | -114.1 | |||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -17.8 | -5.3 | 60.4 | |||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 206.4 | 123.4 | 342.2 | |||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -197.8 | -157.3 | -169.8 | |||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -186.3 | |||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 187.2 | 74.4 | 0 | |||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -10.6 | -82.9 | -356.1 | |||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -9.4 | -0.1 | -45.3 | |||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 2.8 | 3 | 3.2 | |||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0.9 | 1 | 46.1 | |||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -183.2 | -208.3 | -166.7 | |||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 4.3 | -14 | -10.2 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -184.5 | -218.4 | -172.9 | |||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 2.4 | 0.2 | -1 | |||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 30 | -6.2 | 24.5 | |||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 113.3 | 83.3 | 89.5 | |||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 83.3 | 89.5 | 65 | |||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 222.9 | 300.4 | 575 | |||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -197.8 | -157.3 | -169.8 | |||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 25.2 | 143.1 | 405.1 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1486.9 | 1521.3 | 1791.4 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 601.6 | 582.6 | 667.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 885.3 | 938.7 | 1124.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -7.6 | 40.2 | 32.4 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 567.4 | 506.8 | 490.4 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1168.9 | 1089.4 | 1157.6 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 2.4 | 2.4 | 1.4 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 6.3 | 4.5 | 4.6 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -11 | 35.1 | 26.6 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -7.6 | 40.2 | 32.4 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -11 | 35.1 | 26.6 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 6.3 | 4.5 | 4.6 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 92.7 | 88.9 | 78.2 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 318 | 431.9 | 633.8 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 307 | 467 | 660.4 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 72.7 | 117.9 | 178.4 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 250.3 | 376.9 | 524.2 |
Często zadawane pytania
Ile wynosi Fisher & Paykel Healthcare Corporation Limited (FPH.AX) aktywów ogółem?
Fisher & Paykel Healthcare Corporation Limited (FPH.AX) całkowite aktywa to 2063359237.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.601.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.051.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.153.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.219.
Co to jest Fisher & Paykel Healthcare Corporation Limited (FPH.AX) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 250300000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 136465310.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 567388691.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.